Latest News in the pharma Industry
Research & Development
.jpg)
European patent granted for amatoxin conjugates for tumor therapy
31 Mar 2020
The patent covers the crosslinking of certain carrier molecules, for example, antibodies, via specific binding sites to amatoxins.
Read more.jpg)
New blood test able to detect 50 cancer types
31 Mar 2020
Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located.
Read more.jpg)
Alvotech and DKSH partner to bring key biosimilar to Asia
24 Mar 2020
Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide.
Read more.jpg)
Positive update on the development of new XF‐platform drug formulations
24 Mar 2020
Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.
Read more
ProBioGen selected for development and large-scale manufacturing services
24 Mar 2020
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.
Read more.jpg)
Codexis and Takeda collaborate to advance novel gene therapies
23 Mar 2020
Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies.
Read more.jpg)
Vaxxas HD-MAP to deliver vaccines directly to the skin
17 Mar 2020
Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.
Read more.jpg)
Technique improves drug delivery system characterization
16 Mar 2020
Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.
Read more.jpg)
Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19
16 Mar 2020
The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.
Read more
Sartorius simplifies biologics production with new bioreactor
9 Mar 2020
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.
Read more.jpg)
Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial
9 Mar 2020
Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.
Read more.jpg)
Nanoform and Orion collaborate on 'nanoformed' APIs
9 Mar 2020
Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.
Read more